| Literature DB >> 18729010 |
Abstract
Hematide is a synthetic peptide-based erythropoiesis-stimulating agent that is being developed by Affymax Inc and Takeda Pharmaceutical Co Ltd. Hematide is undergoing phase III clinical trials for anemia.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18729010
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN: 1472-4472